Iqvia Holdings (IQV) Other Accumulated Expenses (2012 - 2026)
Iqvia Holdings' (IQV) quarterly Other Accumulated Expenses came in at $457.0 million in Q2 2026, down 25.45% year-over-year from $613.0 million in Q2 2025, and up 10.65% quarter-over-quarter from $413.0 million in Q1 2026.
Analysis
Iqvia Holdings (IQV) Other Accumulated Expenses (2012 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Other Accumulated Expenses across 15 years of filings, most recently posting $457.0 million for Q2 2026.
- In Q2 2026, Other Accumulated Expenses fell 25.45% year-over-year to $457.0 million; the TTM figure through Jun 2026 stood at $457.0 million (down 25.45% YoY), while the FY2025 annual figure was $489.0 million, up 36.21% from the prior year.
- Other Accumulated Expenses came in at $457.0 million for Q2 2026 at Iqvia Holdings, up from $413.0 million in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $613.0 million in Q2 2025 to a low of $137.0 million in Q3 2023.
- Average Other Accumulated Expenses over 5 years is $307.4 million, with a median of $325.0 million recorded in 2023.
- Year-over-year, Other Accumulated Expenses jumped 325.69% in 2025 and fell 25.45% in 2026.
- Over 5 years, Other Accumulated Expenses stood at $368.0 million in 2022, then slipped by 10.05% to $331.0 million in 2023, then rose by 8.46% to $359.0 million in 2024, then jumped by 36.21% to $489.0 million in 2025, then declined by 6.54% to $457.0 million in 2026.
- Per Business Quant data, the three most recent Other Accumulated Expenses figures were $457.0 million in Q2 2026, $413.0 million in Q1 2026, and $489.0 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 457.00 Mn |
| Mar 31, 2026 | 413.00 Mn |
| Dec 31, 2025 | 489.00 Mn |
| Sep 30, 2025 | 515.00 Mn |
| Jun 30, 2025 | 613.00 Mn |
| Mar 31, 2025 | 319.00 Mn |
| Dec 31, 2024 | 359.00 Mn |
| Sep 30, 2024 | 354.00 Mn |
| Jun 30, 2024 | 144.00 Mn |
| Mar 31, 2024 | 207.00 Mn |
| Dec 31, 2023 | 331.00 Mn |
| Sep 30, 2023 | 137.00 Mn |
| Jun 30, 2023 | 140.00 Mn |
| Mar 31, 2023 | 157.00 Mn |
| Dec 31, 2022 | 368.00 Mn |
| Sep 30, 2022 | 165.00 Mn |
| Jun 30, 2022 | 177.00 Mn |
| Mar 31, 2022 | 189.00 Mn |
| Dec 31, 2021 | 311.00 Mn |
| Sep 30, 2021 | 214.00 Mn |